Green Cross Cell Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Green Cross Cell Corp with three other
companies in this sector in South Korea:
Pharmicell Company Limited
sales of 28.35 billion Korean Won [US$23.82 million]
of which 82%
WooGene B&G CO., LTD
(30.62 billion Korean Won [US$25.72 million]
Eagle Veterinary Technology Co., Ltd
(30.26 billion Korean Won [US$25.42 million]
Green Cross Cell Corp reported sales of 29.61 billion Korean Won (US$24.87 million)
December of 2018.
increase of 51.5%
versus 2017, when the company's sales were 19.54 billion Korean Won.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Green Cross Cell Corp had sales
of 29.87 billion Korean Won.